Spectral AI, Inc. (MDAI)
NASDAQ: MDAI · Real-Time Price · USD
1.410
+0.010 (0.71%)
At close: Mar 9, 2026, 4:00 PM EDT
1.360
-0.050 (-3.55%)
After-hours: Mar 9, 2026, 4:35 PM EDT

Company Description

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.

The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds.

Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software.

Spectral AI, Inc. is headquartered in Dallas, Texas.

Spectral AI, Inc.
Spectral AI logo
Country United States
Founded 2013
Industry Medical Devices
Sector Healthcare
Employees 78
CEO Vincent Capone

Contact Details

Address:
2515 McKinney Avenue, Suite 1000
Dallas, Texas 75201
United States
Phone 972 499 4934
Website spectral-ai.com

Stock Details

Ticker Symbol MDAI
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001833498
CUSIP Number 84757T105
ISIN Number US84757T1051
SIC Code 3841

Key Executives

Name Position
Wensheng Fan Co-Founder, Chief Innovation Strategist and Senior Advisor to the Chief Executive Officer
Vincent Stanley Capone Esq. Chief Executive Officer and Corporate Secretary
Dr. John Michael DiMaio M.D. Founder and Chairman
Stanley Micek Chief Operating Officer
Louis Percoco General Manager
Allison Kumar Head of Global Regulatory Affairs

Latest SEC Filings

Date Type Title
Feb 11, 2026 SCHEDULE 13G Filing
Feb 10, 2026 8-K Current Report
Feb 3, 2026 8-K Current Report
Jan 6, 2026 8-K Current Report
Nov 13, 2025 10-Q Quarterly Report
Oct 30, 2025 S-3 Registration statement under Securities Act of 1933
Oct 24, 2025 8-K Current Report
Oct 23, 2025 424B5 Filing
Aug 14, 2025 SCHEDULE 13G/A Filing
Aug 13, 2025 8-K Current Report